SCPH - scPharmaceuticals Inc
IEX Last Trade
5.1
0.060 1.176%
Share volume: 126,239
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.04
0.06
1.19%
Fundamental analysis
24%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
21%
Performance
5 Days
-5.21%
1 Month
5.38%
3 Months
26.93%
6 Months
-15.45%
1 Year
-34.15%
2 Year
-12.69%
Key data
Stock price
$5.10
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.24 - $7.71
52 WEEK CHANGE
-$0.32
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: John Tucker
Region: US
Website: http://www.scpharmaceuticals.com/
Employees: 88
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.scpharmaceuticals.com/
Employees: 88
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.
Recent news